一个对刺激有反应性的cuproptosis开关增强了持续免疫疗法用于瘤根除
Jinming Cai1, Sheng Shi2, Jinyan Hu1
1School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China.
Biomaterials
|December 20, 2025
概括
一个新型的pH敏感纳米囊通过精确释放铜离子和免疫激动剂,触发癌症特异性的亡 (依赖铜的细胞死亡). 这种方法增强了瘤治疗,并且在小鼠中消除了瘤,副作用最小.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 铜,一种依赖铜的细胞死亡,提供了新的癌症治疗潜力.
- 目前的铜灭诱导剂面临的挑战是无特异性的铜释放和低瘤积累.
- 精确控制铜离子释放对于有效和安全的体内癌症治疗至关重要.
研究的目的:
- 设计一种对刺激有反应的"cuproptosis开关",用于癌症特异性的cuproptosis诱导.
- 通过将其与免疫应答激活相结合,增强cuproptosis向治疗的疗效.
- 为了研究 cuproptosis 敏感化的机制,并在体内评估抗瘤疗效.
主要方法:
- 开发一个双层铜纳米囊 (Cu2O和Cu2-xSe外) 具有pH敏感的铜离子释放.
- 在纳米囊中封装MSA-2,一种STING激活激动剂.
- 评估超声波 (US) 照射和MSA-2释放诱导的cuproptosis敏感化机制 (离子载体调节,GSH耗尽,线粒体透性).
- 在小鼠模型中对瘤消除,免疫细胞死亡和cGAS-STING通路激活的联合治疗效应的评估.
主要成果:
- 纳米囊在pH值6.8时显示了类似开关的,pH值依赖的Cu+释放,使得癌症特定的输送.
- 美国辐射和MSA-2通过调节铜恒温和耗尽GSH来释放协同敏感的细胞对铜亡.
- 结合疗法诱导了瘤特异性缩,启动了免疫细胞死亡,激活了cGAS-STING通路,并导致小鼠在低剂量下完全消除瘤,没有可观察到的副作用.
结论:
- 开发的美国敏感化的cuproptosis开关为癌症治疗提供了一个精确和有效的平台.
- 这种方法有望消除原发性瘤和腹腔转移性焦点,可能导致完全瘤根除.
- 该战略强调了将向细胞死亡诱导与免疫系统激活相结合的潜力,以获得持久的抗瘤反应.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.6K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Adaptive Mechanisms in Cancer Cells
6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
